Table 1.

Demographics of patients included in neopterin analysis.

Parameter	Combination therapy arm	Monotherapy arm	Both arms	Significance
Total no. of patients	48	48	96	n.s.a
Female patients [no. (%)]	6 (12.5)	7 (14.6)	13 (13.5)	n.s.a
Pediatric patients (≤12 year) [no. (%)]	26 (54.2)	21 (43.8)	47 (49.0)	n.s.a
Age (yr)	14 (7–30)	15 (7–41)	15 (7–41)	n.s.b
Body weight (kg)	35 (15–59)	37 (16–65)	36 (15–65)	n.s.b
TREATMENT OUTCOME
Patients with initial failure [no. (%)]	2 (4.2)	2 (4.2)	4 (4.2)	n.s.c
Patients with relapse [no. (%)]	6 (12.5)	9 (18.8)	15 (15.6)
Patients that cure [no.(%)]	40 (83.3)	37 (77.1)	77 (80.2)
TREATMENT CENTERS
Kimalel, Kenya [no. (%)]	25 (52.1)	24 (50.0)	49 (51.0)	n.s.c
Kassab, Sudan [no. (%)]	6 (12.5)	7 (14.6)	13 (13.5)
Dooka, Sudan [no. (%)]	17 (35.4)	17 (35.4)	34 (35.4)

All values are given as median (range), unless stated otherwise.

^aFisher exact test.

^bWilcoxon u-test.

^cChi-square test.